Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 06:49 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Predicting, Understanding and Speeding Recovery After TKA
NCT02685735 · Wake Forest University Health Sciences · PHASE4 · terminated · last registry update 2025-08-15 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “lack of continued funding support” | – | Registry record, Wake Forest University Health Sciences |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CACNA1H within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2026-07-07Results posted on the registry: University of Kansas Medical Center, Tylenol + Oxycodone (NCT04246697)
- 2026-06-04Phase 3 first posted: Rehman Medical Institute - RMI, oxcarbamezapine(300 mg twice daily) + combination therapy(oxcarbamezapine 300 mg twice daily and gabapentine) (NCT07625410)
- 2026-06-03Results posted on the registry: Mayo Clinic, Oxycodone + Ibuprofen (NCT05076110)
- 2026-04-16Results posted on the registry: Roswell Park Cancer Institute, Gabapentin + Methadone (NCT03574792)
- 2026-04-01Results posted on the registry: Jocelyn Fitzgerald, Multimodal Bundle Drugs + Bladder Instillation (NCT05658874)
- 2026-04-01Also stopped (terminated): Jocelyn Fitzgerald, Multimodal Bundle Drugs + Bladder Instillation (NCT05658874)
- 2026-03-19Results posted on the registry: Henry Ford Health System, Celecoxib + Hydrocodone-Acetaminophen (NCT03818932)
- 2026-02-24Phase 3 first posted: Mansoura University, solifenacin combined with gabapentin + solifenacin monotherapy (NCT07429734)
- 2026-01-20Phase 3 first posted: Assiut University, Valacyclovir + Paracetamol (Acetaminophen) + Gabapentin (standard medical therapy) (NCT07349680)
- 2026-01-06Results posted on the registry: CAMC Health System, Pregabalin 50mg + Gabapentin 300mg (NCT04705480)
- 2025-12-22Phase 3 first posted: University of California, San Francisco, Pharmacologic Pain Management (NCT07296770)
- 2025-08-12Results posted on the registry: Joseph Kowalski, Gabapentin + Gabapentin Placebo (NCT05658887)
- 2025-07-31Results posted on the registry: Washington University School of Medicine, Bupivacaine + Morphine (NCT05017246)
- 2025-07-31Also stopped (terminated): Washington University School of Medicine, Bupivacaine + Morphine (NCT05017246)
- 2025-07-08Results posted on the registry: Mario Negri Institute for Pharmacological Research, Low dose carbamazepine + Standard dose carbamazepine (NCT03689114)
- 2025-07-02Phase 3 first posted: Assiut University, Ketorolac Tromethamine 30 MG/ML Prefilled Syringe + Gabapentin (NCT07047040)
- 2025-06-11Results posted on the registry: The University of Texas Health Science Center, Houston, Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol) + Dronabinol (NCT05820685)
- 2025-06-11Also stopped (terminated): The University of Texas Health Science Center, Houston, Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol) + Dronabinol (NCT05820685)
- 2025-06-03Also stopped (withdrawn): University of Miami, Acetaminophen + Celebrex (NCT05965492)
- 2025-05-28Phase 3 first posted: Alliance for Clinical Trials in Oncology, Gabapentin + Placebo (NCT06992427)
- 2025-05-18Results posted on the registry: VA Office of Research and Development, a drug against CACNA1H (NCT04294901)
- 2025-04-11Also stopped (withdrawn): Stanford University, Topamax + Gabapentin (NCT04613024)
- 2025-03-21Phase 3 first posted: Cairo University, Gabapentin 600 mg capsules + Gabapentin 400 mg capsules (NCT06887998)
- 2025-03-04Results posted on the registry: Washington University School of Medicine, Gabapentin gelatin capsules 300mg + Placebo (NCT05184192)
- 2024-12-27Results posted on the registry: Dompé Farmaceutici S.p.A, Ketoprofen Lysine Salt combined with Gabapentin + Ketoprofen Lysine Salt (NCT04802967)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision